-
Product Insights
NewGastrin/Cholecystokinin Type B Receptor – Drugs In Development, 2024
The Gastrin/Cholecystokinin Type B Receptor pipeline drugs market research report outlays comprehensive information on the Gastrin/Cholecystokinin Type B Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Gastrointestinal, and Infectious Disease which include indications of Gastric Cancer, Lung Cancer, Alzheimer's Disease, Dementia, Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Helicobacter pylori Infections, and Coronavirus...
-
Product Insights
NewC-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Undisclosed which include indications of Non-Hodgkin Lymphoma, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Asthma, Allergic Asthma, Atopic Dermatitis (Atopic Eczema), Chronic Urticaria Or Hives, and...
-
Product Insights
NewLeukocyte Immunoglobulin Like Receptor Subfamily B Member 1 – Drugs In Development, 2024
The Leukocyte Immunoglobulin Like Receptor Subfamily B Member 1 pipeline drugs market research report outlays comprehensive information on the Leukocyte Immunoglobulin Like Receptor Subfamily B Member 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Leukocyte Immunoglobulin Like Receptor Subfamily...
-
Product Insights
NewLeukocyte Immunoglobulin Like Receptor Subfamily B Member 4 – Drugs In Development, 2024
The Leukocyte Immunoglobulin Like Receptor Subfamily B Member 4 pipeline drugs market research report outlays comprehensive information on the Leukocyte Immunoglobulin Like Receptor Subfamily B Member 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in Leukocyte Immunoglobulin Like Receptor Subfamily...
-
Product Insights
NewAurora Kinase B – Drugs In Development, 2024
The Aurora Kinase B pipeline drugs market research report outlays comprehensive information on the Aurora Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Gastric Cancer. It also reviews key players involved in Aurora Kinase B targeted therapeutics development with respective active and...
-
Product Insights
NewCD27 Antigen – Drugs In Development, 2024
The CD27 Antigen pipeline drugs market research report outlays comprehensive information on the CD27 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Immunology which include indications of Solid Tumor, Unspecified B-Cell Lymphomas, Autoimmune Disorders, and Inflammation. It also reviews key players involved in CD27 Antigen targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewNKG2 A/NKG2 B Type II Integral Membrane Protein – Drugs In Development, 2024
The NKG2 A/NKG2 B Type II Integral Membrane Protein pipeline drugs market research report outlays comprehensive information on the NKG2 A/NKG2 B Type II Integral Membrane Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Solid Tumor, Unspecified Cancer, and Coronavirus Disease 2019 (COVID-19). It also reviews key players...
-
Product Insights
NewPolycomb Protein EED – Drugs In Development, 2024
The Polycomb Protein EED pipeline drugs market research report outlays comprehensive information on the Polycomb Protein EED targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Hematological Disorders, and Undisclosed which include indications of Diffuse Large B-Cell Lymphoma, Solid Tumor, Anemia, Sickle Cell Disease, and Unspecified Rare Disease. It also reviews key players involved in Polycomb Protein...
-
Product Insights
NewVascular Endothelial Growth Factor B – Drugs In Development, 2024
The Vascular Endothelial Growth Factor B pipeline drugs market research report outlays comprehensive information on the Vascular Endothelial Growth Factor B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, and Oncology which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Solid Tumor, and Metastatic Colorectal Cancer. It also reviews key players involved...
-
Product Insights
NewLow Affinity Immunoglobulin Gamma Fc Region Receptor II-b – Drugs In Development, 2024
The Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b pipeline drugs market research report outlays comprehensive information on the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Undisclosed, and Respiratory which include indications of Autoimmune Disorders, Systemic Lupus Erythematosus, Solid Tumor, Lymphoma, Unspecified, and Allergic Asthma. It...